Karo Pharma Revenue and Competitors

Claim your profile

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Karo Pharma's estimated annual revenue is currently $82.4M per year.(i)
  • Karo Pharma's estimated revenue per employee is $201,000

Employee Data

  • Karo Pharma has 410 Employees.(i)
  • Karo Pharma grew their employee count by 22% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$15M87N/AN/AN/A

Karo Pharma is a specialty pharma company that develops, markets and sells pharmaceuticals, OTC-products and hospital supplies. With a strong portfolio of well-known brands, the company has a solid position among pharmacies and the health care sector in the region. Our vision is to become a leading specialty pharma company. Our goal is to achieve greater shareholder value through organic growth and acquisitions, maintaining a solid profit margin. During recent years Karo Pharma has grown rapidly via strategic acquisitions of companies and brands with an established position on the market or with a short time to market. We aim at keeping a lean organization with high competence and efficiency. In 2017 Karo Pharma acquired Weifa, a leading OTC- and pharmaceutical company in Norway. In April 2018 Karo Pharma acquired a product portfolio with an annual turnover of around 700 MSEK from the Danish pharmaceutical company LEO Pharma A/S Karo Pharma is listed on the Nasdaq Stockholm Mid Cap list (karo.st) and the headquarter is located in Stockholm. Our Products and Brands: Pain/fever: Paracet, Ibux, Proxan, Fanalgin Cold: Dexyl, Tussin, Nazamér, Bronkyl, Solvivo Wounds: Pyrisept, Pyricare, Adelli Prescription drugs: Molllipect, Laxabon, Lithionit, Paraflex, Zonat, Paralgin Forte, Samin, Conotrane, Fonx, Condyline, Synalar, Mildison, Centyl, Kaleorid, Burinex and Selexid and more Mabs - CE-marked compression stockings (www.mabs.se) Allévo - healthy products for weight control (www.allevo.nu) Swereco - medical devices and hospital supplies (www.swereco.se) BabySlide - helps prevent ruptures during child birth (www.babyslide.com) Dosett - correct medicine dosage (www.dosett.com) Locobase - Nr. 1 skincare band at Swedish pharmacies (www.locobase.se) Other Brands: Complete, Vagisan, Plantur, Slicks, Zippy, Triolif, Asan and more

keywords:N/A

N/A

Total Funding

410

Number of Employees

$82.4M

Revenue (est)

22%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Karo Pharma News

2022-04-17 - Sylphar NV and Karo Pharma AB's Purchase of Satin Naturel

Sylphar NV and Karo Pharma AB purchased the Satin Naturel business from Del Decus Enterprises Ltd. With a high-quality aloe vera-based product...

2022-04-17 - White & Case advises Karo Pharma AB on SEK 2.5 billion ...

Karo Pharma completed its acquisition of Sylphar on 13 January 2022. The rights issue will repay a bridge loan facility related to the...

2022-04-06 - Kirkland & Ellis hires Allen & Overy lawyer as antitrust partner ...

Balfour was part of the team that advised Reckitt Benckiser Group in the sale of its E45 and other related brands to Karo Pharma,...

2021-09-07 - Anna Hale appointed CMO at Karo Pharma

Anna Hale appointed CMO at Karo Pharma Tue, Sep 07, 2021 08:00 CET Karo Pharma Aktiebolag (publ) (“Karo”) has appointed Anna Hale as the Chief Marketing Officer (CMO) of Karo. The appointment reflects Karo’s growth ambitions, fueled by a strategy of geographical expansion and development of its ...

2021-08-24 - Magnus Nylén leaves Karo Pharma, Matt Roberts appointed new CCO

Magnus Nylén leaves Karo Pharma, Matt Roberts appointed new CCO Tue, Aug 24, 2021 08:00 CET Karo Pharma Aktiebolag (“Karo”) has appointed Matt Roberts as the new Chief Commercial Officer (CCO) of Karo, replacing Magnus Nylén who has decided to pursue opportunities outside of Karo. Matt will sta ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$88.6M41228%N/A
#2
$140.7M41747%N/A
#3
$116.9M425-11%N/A
#4
$74.9M4282%N/A
#5
$122.9M433-2%N/A